AHG - Company ID 0001702318
The table below shows Akso Health Group's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Revenue | $13.83M | $14.78M | $2.41M | $13.18M | $6.00M | $1.75M |
| Cost of revenue | $13.84M | $15.06M | $2.29M | $11.91M | $5.39M | $544.57K |
| Gross profit | -$11.31K | -$281.53K | $122.13K | $1.27M | $605.13K | $1.75M |
| R&D | - | - | - | - | $421.19K | $441.40K |
Akso Health Group reported annual revenue of $13.83M for fiscal year 2026. That is down 6.4% from $14.78M in fiscal 2025. Over the 10 fiscal years shown, annual revenue declined from $22.92M (FY 2017) to $13.83M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $3.99M |
| $3.64M |
| $8.59M |
| $15.53M |
| $2.67M |
| $2.03M |
| Operating income | -$20.70M | -$166.30M | -$8.64M | -$14.27M | -$3.26M | -$4.24M |
| Income tax | -$1.99M | -$30.80M | $24.99K | $17.55K | $92.82K | $482.98K |
| Net income | -$18.67M | -$134.98M | -$9.46M | -$1.36M | -$16.85M | -$34.83M |
| EPS (diluted) | $0.01 | -$0.16 | -$0.07 | -$0.02 | -$0.28 | -$0.71 |